Promoter effect of medroxyprogesterone acetate (MPA) in N-methyl-N-nitrosourea (MNU) induced mammary tumors in BALB/c mice

The promoter effect of medroxyprogesterone acetate (MPA) on mammary carcinogenesis in female BALB/c mice was investigated using methylnitrosourea (MNU) as initiator. Nine out of 43 animals developed mammary carcinomas in the group treated with MNU (50 mg/kg) and MPA (administration of 40 mg every 3...

Descripción completa

Guardado en:

Detalles Bibliográficos
Publicado:	1998
Materias:	estrogen receptor medroxyprogesterone acetate methylnitrosourea progesterone receptor animal experiment animal model animal tissue article breast adenocarcinoma breast carcinogenesis breast tumor cell differentiation controlled study female mouse nonhuman priority journal promoter region Adenocarcinoma Animals Carcinogens Cocarcinogenesis Female Mammary Neoplasms, Experimental Medroxyprogesterone 17-Acetate Methylnitrosourea Mice Mice, Inbred BALB C
Acceso en línea:	https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01433334_v19_n3_p529_Pazos http://hdl.handle.net/20.500.12110/paper_01433334_v19_n3_p529_Pazos
Aporte de:	Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

Ejemplares similares

Promoter effect of medroxyprogesterone acetate (MPA) in N-methyl-N-nitrosourea (MNU) induced mammary tumors in BALB/c mice
por: Pazos, P., et al.

Protective role of medroxyprogesterone acetate on N-methyl-N-nitrosourea-induced lymphomas in BALB/c female mice
Publicado: (2001)

Protective role of medroxyprogesterone acetate on N-methyl-N-nitrosourea-induced lymphomas in BALB/c female mice
por: Pazos, P., et al.

Insulin-like growth factor-I production and receptors in mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice
Publicado: (1990)

Insulin-like growth factor-I production and receptors in mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice
por: Elizalde, P.V., et al.

Transforming growth factor-β activities in 'in vivo' lines of hormone-dependent and independent mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice
por: Elizalde, Patricia Virginia, et al.
Publicado: (1990)

Transforming growth factor-β activities in 'in vivo' lines of hormone-dependent and independent mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice
por: Elizalde, P.V., et al.

Involvement of insulin-like growth factors-I and-II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas
Publicado: (1998)

Involvement of insulin-like growth factors-I and-II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas
por: Elizalde, P.V., et al.

Correlation of TGF-(si expression with medroxiprogesterone acetate responsiveness in mouse mammary adenocarcinomas
Publicado: (1995)

Correlation of TGF-(si expression with medroxiprogesterone acetate responsiveness in mouse mammary adenocarcinomas
por: Elizalde, P.V., et al.

Reversal of estrogen-resistance in murine mammary adenocarcinomas
Publicado: (1999)

Reversal of estrogen-resistance in murine mammary adenocarcinomas
por: Montecchia, M.F., et al.

Induccion de adenocarcinomas mamarios por progestagenos en ratones BALB/c: Progresion del tumor hormono-dependiente al autonomo
Publicado: (1997)

Induccion de adenocarcinomas mamarios por progestagenos en ratones BALB/c: Progresion del tumor hormono-dependiente al autonomo
por: Lanari, C., et al.

Expansion of CD11b⁺Ly6G⁺Ly6C<sup>int</sup> cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions
por: Spallanzani, Raúl Germán, et al.
Publicado: (2013)

Effects of ω-3 PUFA-enriched diet on growth parameters in a syngenic murine model of breast adenocarcinoma: a possible role for estrogen receptor alpha
por: Vara Messler, Marianela, et al.
Publicado: (2022)

Type I insulin-like growth factor receptor antisense strategies in experimental breast cancer
Publicado: (2004)

Type I insulin-like growth factor receptor antisense strategies in experimental breast cancer
por: Salatino, M., et al.

Association of estrogen receptor-α and progesterone receptor A expression with hormonal mammary carcinogenesis: Role of the host microenvironment
Publicado: (2007)

Association of estrogen receptor-α and progesterone receptor A expression with hormonal mammary carcinogenesis: Role of the host microenvironment
por: Montero Girard, G., et al.

Cytogenetic findings, Trp53 mutations, and hormone responsiveness in a medroxyprogesterone acetate induced murine breast cancer model
Publicado: (2005)

Cytogenetic findings, Trp53 mutations, and hormone responsiveness in a medroxyprogesterone acetate induced murine breast cancer model
por: Fabris, V.T., et al.

Expansion of CD11b+Ly6G+Ly6Cint cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions
por: Ziblat, Andrea, et al.
Publicado: (2013)

Expansion of CD11b+Ly6G+Ly6Cint cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions
por: Spallanzani, R.G., et al.

Factores de crecimiento y oncogenes en adenocarcinomas mamarios inducidos por acetato de medroxyprogesterona en ratones BALB/c
Publicado: (1997)

Factores de crecimiento y oncogenes en adenocarcinomas mamarios inducidos por acetato de medroxyprogesterona en ratones BALB/c
por: Elizalde, P.V., et al.

Role of ACTH on the effect of medroxyprogesterone in brain stem serotonin
Publicado: (1978)

Role of ACTH on the effect of medroxyprogesterone in brain stem serotonin
por: Izquierdo, J.A., et al.

Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insalia-like growth factor receptor in mammary tumor cells
por: Labriola, Leticia, et al.
Publicado: (2001)

Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insalia-like growth factor receptor in mammary tumor cells
por: Balãá, M.E., et al.
Publicado: (2001)

Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insalia-like growth factor receptor in mammary tumor cells
por: Balãá, M.E., et al.

Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insalia-like growth factor receptor in mammary tumor cells
por: Balãá, M.E., et al.
Publicado: (2001)

Categorización histopatológica de la estroma del adenocarcinoma primario de mama: Una propuesta de posible valor pronóstico
por: Negri, I, et al.
Publicado: (2024)

Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas
Publicado: (1999)

Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas
por: Balañá, M.E., et al.

Synergistic effect of mammary tumors on hexachlorobenzene-induced porphyria in rats
por: Wainstok de Calmanovici, Rosa, et al.
Publicado: (1990)

Synergistic effect of mammary tumors on hexachlorobenzene-induced porphyria in rats
por: Wainstok de Calmanovici, R., et al.

Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy
Publicado: (2013)

Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy
por: Díaz Flaqué, M.C., et al.